Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-002396-42Phase 3Completed
Phase 3, randomised, double-blind trial of drospirenone (2 arms), sponsored by Laboratorios Leon Farma. Primary endpoint: Overall Pearl Index. Started Dec 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-002396-42.